---
title: "Cellectis reports 100,701,207 issued shares, 105,554,794 voting rights as of July 31, 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295011710.md"
description: "Cellectis reported 100,701,207 issued shares and 105,554,794 voting rights as of July 31, 2026. The company published this information on August 5, 2026."
datetime: "2026-08-05T20:38:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295011710.md)
  - [en](https://longbridge.com/en/news/295011710.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295011710.md)
generator: "portal-rs"
---

# Cellectis reports 100,701,207 issued shares, 105,554,794 voting rights as of July 31, 2026

-   Cellectis reported 100,701,207 issued shares as of July 31, 2026. \* Total voting rights stood at 105,554,794 on the same date. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellectis SA published the original content used to generate this news brief on August 05, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [CLLS.US](https://longbridge.com/en/quote/CLLS.US.md)

## Related News & Research

- [Cellectis discloses 100,718,974 issued shares, 105,568,956 voting rights as of Aug. 31](https://longbridge.com/en/news/297955739.md)
- [Cellectis to present at Baird Global Healthcare Conference](https://longbridge.com/en/news/297695285.md)
- [Veidekke discloses 2026 share awards for senior executives](https://longbridge.com/en/news/298448651.md)
- [Essex Property Trust declares Q3 2026 dividend of R$ 0.89 per unit](https://longbridge.com/en/news/298322539.md)
- [HF Sinclair announces Q3 2026 dividend of R$ 1.81 per unit](https://longbridge.com/en/news/298317474.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**